| |
Companies That Interview PhD-Level Job Candidates
 |
3M
3M is one of the world's premier manufacturing companies. We employ
more than 70,000 people, have operations in more than 60 countries
and do business in over 100 countries. |
|
 |
Abbott
Laboratories
As one of the world's leading health care companies, Abbott Laboratories
is dedicated to improving people's lives through the discovery, development,
manufacture and marketing of pharmaceuticals, nutritionals, and medical
products, including devices and diagnostics. From the discovery of
sodium pentothal to a groundbreaking new generation of HIV protease
inhibitors, Abbott scientists have played an important part in making
life better for patients around the world. That tradition continues
today at Abbott with over thirty compounds in preclinical development
and a high success rate of advancing compounds to the clinic, with
a pipeline that has been described as "an array of development
efforts that are pioneering with blockbuster potential". |
|
 |
Air
Products and Chemicals
Air Products and Chemicals, Inc. (NYSE:APD) is the world's only combined
gases and chemicals company. Founded more than 60 years ago and headquartered
in eastern Pennsylvania's Lehigh Valley, the company has annual revenues
of $5.7 billion and operations in 30 countries. Air Products is a
market leader in the global electronics and chemical processing industries,
and a long-standing innovator in many industrial markets, including
coatings, adhesives and polyurethanes. The company distinguishes itself
through its 18,000 employees around the world, who build lasting relationships
with their customers and communities based on understanding, integrity
and passion. |
|
 |
Albany
Molecular Research, Inc.
Albany Molecular Research, Inc. (NASDAQ: AMRI) is a chemistry-based
drug discovery and development company, focusing on applications
for new small molecule prescription drugs. The company conducts
R&D projects and collaborates with many leading pharmaceutical,
biotechnology and genomics companies, and is developing new chemistry
technology for potential prescription drug applications. AMRI has
established relationships with over 160 companies worldwide. AMRI
resources include 547 experienced scientists, managers and support
personnel, and state-of-the-art facilities in upstate New York,
as well as the Chicago, IL and Seattle, WA areas. |
|
 |
Amgen,
Inc.
Amgen, the world's largest independent biotechnology company, was
founded in Thousand Oaks, California in 1980. Amgen's corporate mission
is to be the world leader in discovering, developing and manufacturing
cost-effective human therapeutics based on advances in cellular and
molecular biology.
We aspire to be the best human therapeutics company. We will live
the Amgen values and use science and innovation to dramatically improve
people's lives. |
|
 |
ArQule,
Inc.
ArQule is a drug discovery company with over 400 employees in four
locations (Woburn and Medford, MA, Redwood City, CA and Cambridge,
UK).
ArQule designs optimal chemical entities (OCEs) using a multi-disciplinary
approach that integrates intelligent molecule design and high-throughput,
automated chemistry, in parallel, with predictive modeling of ADMET
(absorption, distribution, metabolism, elimination, toxicity) parameters. |
|
 |
Array
BioPharma
Headquartered in beautiful Boulder, Colorado, Array BioPharma(NASDAQ:ARRY)is
a drug discovery company creating new small molecule drugs through
the integration of chemistry, biology and informatics. We focus our
research on important therapeutic areas such as cancer, arthritis
and asthma. Joining Array means being part of a world-class group
of scientists and making a difference. Array continues to grow and
will add over forty scientists this year to our team. If you enjoy
organic chemistry and have a passion for innovation, Array is the
place for you. |
|
 |
AstraZeneca
AstraZeneca is one of the world's leading pharmaceutical companies.
Backed by a strong research base and extensive manufacturing and commercial
skills, the company provides a powerful range of products for seven
important areas of healthcare - gastrointestinal, cardiovascular,
cancer, respiratory, central nervous system, pain control and infection.
Headquartered in the UK, with R&D headquarters in Sweden and a
strong presence in the key US market, AstraZeneca sells in over 100
countries, manufactures in 20 and has major research centres in 5.
It employs over 54,000 people worldwide and values the diversity of
skills and abilities that they bring to the business. |
|
 |
ATOFINA
Chemicals
ATOFINA Chemicals,Inc. employs 3000 people and reported sales in 2002
of $1.4 billion. ATOFINA Chemicals is part of ATOFINA, the world's
6th largest chemical company with 71,500 employees and sales in 2002
of $18.2 billion. ATOFINA is the chemical branch of TOTAL (NYSE: TOT),
the world's 4th largest oil and gas company with 121,000 employees
and sales in 2002 of $97.6 billion. We enjoy ongoing collaboration
with ATOFINA colleagues at research centers in Pierre Benite, Serquigny,
and Lacq, France, and Kyoto, Japan, as well as at ATOFINA petrochemicals
research centers in Feluy, Belgium adn LaPorte, Texas. Thus, we can
offer many different career pathways in a dynamic, international environment. |
|
 |
Aventis
Aventis is a world leader in the discovery, development and marketing
of innovative pharmaceutical products. We aim to create and sustain
value by being recognized as a pharmaceutical industry leader valued
by patients and healthcare providers, sought after as an employer,
and respected by the scientific community and by our competitors.
|
|
 |
Bayer
Corporation
Bayer Corporation expects to hire several recent PhD-level scientists/engineers
to work in the Plastics, Polyurethanes, and Coating Divisions. These
individuals are responsible for research and development projects
with the goal of developing new materials or processes of immediate
or long-term interest to the Bayer divisions. Incumbents will participate
in cooperative research projects and interactions within Bayer Corp.
and with Bayer AG (Germany) with the intention of coordinating research
activities and transferring results. |
|
 |
Beyond
Genomics
Beyond Genomics develops and applies advanced research technologies
and methods for understanding Systems Biology. Using our technology
platform to analyze clinically relevant samples and integrate data
from the gene, protein, metabolite, and small molecule levels, we
go beyond genomics to provide a more complete picture of the molecular
mechanisms of health and disease. These insights provide pharmaceutical
companies with timely information for accelerating the discovery and
development of more effective products and strategies for diagnosis,
treatment, early detection, and, ultimately, the prevention of disease. |
|
 |
Boehringer
Ingelheim
Boehringer Ingelheim Corporation is the principal U.S. licensee of
Boehringer Ingelheim GmbH, an international chemical and pharmaceutical
firm that develops, produces and sells pharmaceuticals, veterinary
medicines and biologicals, agricultural chemical products and fine,
specialty chemicals in more than 41 countries. Worldwide sales for
the Boehringer Ingelheim group of companies were $5.8 billion in 2000.
Collectively, the U.S. Boehringer Ingelheim companies employ more
than 5,300 people. |
|
 |
Bristol-Myers
Squibb
At Bristol-Myers Squibb, we believe it is our responsibility to explore
the full potential of medical research, including genomics, in treating
and preventing disease and in promoting health. We approach this challenge
with excitement, determination and optimism. |
|
 |
Celera
Envision an exciting future that brings new understandings in science,
technological innovations and drug discoveries to meet the medical
needs of our world. The people at Celera are putting pieces of that
future together every day. |
|
| |
ChemoCentryx,
Inc.
Chemocentryx, world leader in the biology of the chemokine system,
is focusing on discovering potent small molecules that selectively
inhibit chemokine activity for use as novel medicines in autoimmune
and inflammatory disorders, cancer, infectious and cardiovascular
disease and transplant rejection. |
|
 |
Colgate-Palmolive
As a leading consumer products company Colgate-Palmolive is deeply
committed to advancing technology which can address changing consumer
needs throughout the world. In fact, our goal is to use our technology
to create products that will continue to improve the quality of life
for our consumers wherever they live. As a successful business, we
are focused on achieving the consistent growth required to continue
our global success and to make us an even stronger company. We believe
this is the best way to benefit our consumers, our people and our
shareholders. |
|
 |
DOW
Dow is interested in doctoral candididates and post docs with degrees
in analytical, synthetic organic, organometallic, inorganic, polymer
and physical chemistry. |
|
 |
DuPont
Based in Wilmington, Delaware, DuPont delivers science-based solutions
for markets that make a difference in people's lives in food and
nutrition; health care; apparel; home and construction; electronics;
and transportation.
DuPont™, Kevlar®, Nomex®, and SentryGlas® are a
trademark and registered trademarks of E.I. du Pont de Nemours and
Company. |
|
 |
Eisai
Research Institute
Eisai s corporate philosophy focuses on meeting the diverse needs of patients and their families and increasing the benefits that health care provides. We express this philosophy with the phrase human health care, and continue to concentrate efforts on its realization worldwide. Throughout the company s 63 years of operation, drug discovery has been an integral part of its mission to advance human health care for patients and their families, as well as a major contributor to Eisai s success. Today, Eisai is Japan s fourth largest pharmaceutical company, ranking in the top 25 worldwide. Eisai s global R & D efforts are focused in several therapeutic areas, including central nervous system, oncology, gastrointestinal, and inflammatory diseases. Eisai Research Institute (ERI) in Andover, MA, is the center for Eisai s U.S. research and development, with an emphasis on finding new treatments for immune disorders and cancer. |
|
 |
Eli
Lilly and Company
Eli Lilly and Company is an innovation-driven pharmaceutical corporation.
At Lilly, our people are the source of all our abilities and successes.
We employ more than 41,000 people worldwide, market our medicines
in 158 countries and conduct research and development in nine countries.
We are currently interested in interviewing for Ph.D. and Post-doctoral
candidates in the field of organic chemistry. |
|
 |
Exxon/Mobil
Advanced-level chemistry professionals find a variety of opportunities
in the Downstream Research & Engineering and Chemicals areas.
Physical Chemistry and Polymer Chemistry professionals are highly
desirable. |
|
 |
Firmenich
Firmenich is a Swiss, family-owned company, founded in Geneva in 1895.
With 8 chemical production plants and 21 manufacturing facilities,
we are one of the top five companies of the world's flavor & fragrance
industry. For over 100 years, Firmenich has been successfully creating
and manufacturing fragrances and flavors that give our products an
irresistible, worldwide appeal. |
|
 |
GE
GE is a diversified services, technology and manufacturing company
with a commitment to achieving customer success and worldwide leadership
in each of its businesses. GE operates in more than 100 countries
and employs 313,000 people worldwide. |
|
 |
Genentech
Genentech, the founder of the biotechnology industry, is a company
with a quarter-century track record of delivering on the promise of
biotechnology. Today, Genentech is among the world's leading biotech
companies, with 10 protein-based products on the market for serious
or life-threatening medical conditions and 20 projects in the pipeline.
With its strength in all areas of the drug development process --
from research and development to manufacturing and commercialization
-- Genentech continues to transform the possibilities of biotechnology
into improved realities for patients. |
|
 |
Gilead
Sciences Inc.
Gilead Sciences, Inc. is a leading biopharmaceutical company with
the mission to discover, develop and commercialize therapeutics that
advance patient care, while building a thriving worldwide enterprise
and challenging employees to make a difference.
Gilead has five marketed products and focuses its research and clinical
programs on anti-infectives, including antivirals, antifungals and
antibacterials. Headquartered in Foster City, California, Gilead has
operations in the United States, Europe and Australia. |
|
 |
GlaxoSmithKline
GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical
company with a powerful combination of skills and resources that provides
a platform for delivering strong growth in today's rapidly changing
healthcare environment. |
|
 |
Incyte
For more than a decade, Incyte has laid the groundwork for drug discovery
by creating the world's most extensive databases of novel content.
Incyte will lead the way to the future by leveraging its genomic information
to discover cures for the diseases that afflict humanity. In less
than one year, Incyte has created an agile, highly focused and efficient
research organization that has launched and fully staffed three discovery
programs. |
|
 |
Infinity
Pharmaceuticals
Infinity Pharmaceuticals is a chemistry based drug discovery company,
that uses diversity oriented synthesis (DOS) to synthesize radically
different (diverse and complex) molecules as starting points for the
drug discovery process. These unique chemical libraries will be explored
by screening them against cellular models of disease (chemical genetics). |
|
 |
Johnson
& Johnson is the world's most comprehensive and broadly
based manufacturer of health care products, as well as a provider
of related services, for the consumer, pharmaceutical and medical
devices and diagnostics markets. Johnson & Johnson has 200 operating
companies in 54 countries around the world employing 110,300 employees
and selling products in more than 175 countries. The fundamental objective
of Johnson & Johnson is to provide scientifically sound, high
quality products and services to help heal, cure disease and improve
the quality of life. This is a goal that began with the Company's
founding in 1886. |
|
 |
Lexicon
Pharmaceuticals
Lexicon Pharmaceuticals is seeking outstanding research scientists
for our Medicinal Chemistry Department in Princeton, NJ. The position
involves the discovery and optimization of lead compounds using traditional
medicinal chemistry approaches as well as the design and synthesis
of targeted combinatorial libraries directed at novel gene targets.
|
|
 |
Materia,
Inc.
Materia, Inc. is chemical technology company specializing in catalysis.
We provide innovative proprietary technologies, products, and services
to the Life Sciences, Materials, and Chemical Manufacturing industries.
Founded in 1997 by Professor Robert H. Grubbs of Caltech, Materia
is the in leader discovering, developing and commercializing applications
of olefin metathesis and related technologies. |
|
 |
Merck
& Co., Inc.
Merck & Co., Inc. is a leading research-driven pharmaceutical
products and services company. Merck discovers, develops, manufactures
and markets a broad range of innovative products to improve human
and animal health, directly and through its joint ventures.
Chemistry Department interviewees should be organic PhD candidates
or postdoctoral associates. Biological chemistry postdoctoral associates
may be interviewed if scheduling permits. |
|
 |
Metabasis
Therapeutics
Metabasis Therapeutics, Inc. is an exciting, rapidly growing San Diego-based
biopharmaceutical company focused on the discovery and development
of novel, low molecular weight drugs for the treatment of liver-related
diseases. Metabasis has a robust drug candidate pipeline generated
from its discovery of a novel class of drugs for treating diabetes
and a platform technology, known as the HepDirect™ Technology,
that enables drugs to be targeted to the liver. |
|
 |
Millennium
Pharmaceuticals
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company,
applies its comprehensive and integrated science and technology platform
for the discovery and development of breakthrough therapeutic and
predictive medicine products with a goal of delivering personalized
medicine. Millennium is primarily focusing its research and development
and commercialization activities in four key areas: cardiovascular,
oncology, inflammation and metabolic disease. Through the industrialization
of its gene-to-patient platform, Millennium is striving to accelerate
the process of drug discovery and development. |
|
 |
Novartis
Novartis Institutes for BioMedical Research (NIBR), the primary pharmaceutical-research
arm of Novartis, has just opened its new world headquarters in Cambridge,
MA. Focusing on the key therapeutic areas of cardiovascular disease,
diabetes, infectious diseases, functional genomics, and oncology,
we are redefining drug discovery in the post-genomic era. Together
with our parent company, Novartis, our goal is to build the most competitive
and innovative research organization with the most promising pipeline
in the pharmaceuticals industry. Our new state-of-the-art research
facilities comprise 255,000 square feet of laboratory and office space
with another 500,000 sq. ft. currently under renovation, ample space
for the thousand-plus scientists we will recruit by the end of 2004.
A $4 billion investment is slated for these headquarters over the
next decade. |
|
 |
Pfizer
Pfizer Global Research & Development(PGRD) is the research and
development division of Pfizer Inc, a global pharmaceutical company.
Our purpose is to continually expand Pfizer's pharmaceutical and veterinary
medicine product development pipelines. These pipelines are already
considered the strongest in the world, and are well known for producing
dozens of breakthrough drugs. In joining together with Warner-Lambert,
Pfizer has combined the best people and practices to create the world's
largest and most talented biomedical research organization. |
|
 |
Praecis
Pharmaceuticals
Praecis Pharmaceuticals Incorporated is a biotechnology company
focused on the discovery, development and commercialization of pharmaceutical
products that address significant clinical needs using its proprietary
LEAP™ (Ligand Evolution to Active Pharmaceuticals) technology.
LEAP combines the power of biological selection with the advantages
of medicinal chemistry in a unique molecular evolution process.
PRAECIS employed LEAP in the development of PLENAXIS™, its
drug candidate for the treatment of prostate cancer and endometriosis.
PRAECIS also has clinical programs in Alzheimer's disease and non-Hodgkin's
lymphoma, and has other programs in the research or preclinical
development stage. |
|
 |
Procter
& Gamble
Procter & Gamble is a world leader in the research, development,
manufature, and marketing of a wide variety of health care, pharmaceutical,
beauty care, cosmetic and fragrance, food and beverage, laundry and
cleaning, and paper products. We sell more than 300 brands in over
140 countries. Annual sales exceed $40 billion, and our annual R&D
investment is about $2 billion. We employ over 1250 PhD's among our
8000 people in R&D, worldwide. |
|
 |
Rohm
and Haas Company
Rohm and Haas Company is one of the world's largest manufacturers
of specialty chemicals – technologically sophisticated materials
that find their way into applications in a variety of major markets.
Most Rohm and Haas products are never seen by consumers; rather, they
are used by other industries to produce better-performing, high quality
end-products and finished goods. The history of Rohm and Haas has
been a series of innovative technical contributions to science and
industry, usually taking place behind the scenes. |
|
 |
Schering-Plough
As a worldwide, research-based pharmaceutical company, Schering-Plough
is engaged in the discovery, development, manufacturing and marketing
of new therapies and treatment programs that can improve people's
health and extend their lives. |
|
 |
Sepracor
Sepracor Inc. is a research-based pharmaceutical company dedicated
to treating and preventing human disease through the discovery, development,
and commercialization of innovative pharmaceutical products that are
directed toward serving unmet medical needs. Sepracor's drug development
program has yielded an extensive portfolio of pharmaceutical compounds,
including candidates for the treatment of respiratory, urology, and
central nervous system disorders. |
|
 |
Shell
Chemicals
Shell makes and supplies products that ultimately touch everybody's
lives. From computers and telephones to cars, planes and clothes,
many staple elements of everyday life contain petrochemicals in some
shape or form. Through our own operations and our joint ventures,
we constitute one of the largest petrochemical operations in the world.
We aim to improve the performance of end products; increase the value
created for our customers; reduce costs, safety risks, and environmental
impact; raise the job satisfaction of our employees; and enhance the
quality of life in the communities around our companies' locations. |
|
 |
Theravance
Theravance (formerly Advanced Medicine) is a progressive, emerging
pharmaceutical company led by an experienced management team in tandem
with an outstanding Board of Directors. |
|
 |
Tularik
Tularik is an early-stage pharmaceutical company dedicated to discovering
drugs for cancer, immune disorders and metabolic diseases. Emphasis
on first-in-class drugs based on our own internal biology research
and drug design technologies.
Ideal candidates will possess a Ph.D. in organic chemistry. Some postdoctoral
experience is preferred, but not required. |
|
 |
XenoPort,
Inc.
XenoPort, Inc. is an early-stage biopharmaceutical company that
is a leader in development and application of new technologies to
enhance the bioavailability of drugs by exploiting the function
of specific proteins involved in active transport of molecules into
and through cells. |
|
|
|
